FDA Clears Olastrocel Trial Expansion

• by Kathryn Wighton

• June 22, 2026

FDA Approves Low-Dose Macrocyclic Contrast Agent for MRI

The macrocyclic gadolinium-based contrast agent has a recommended dose of 0.01 mmol/kg actual body weight.

• by Kathryn Wighton

• June 15, 2026

• 3 min

Clinical outcomes of internal iliosciatic fixation using a conventional reconstruction plate via an anterior approach for acetabular fractures involving the posterior column

• by Haolan Xiong, Hongfen Chen, Shenglu Cao, Xiaohua Chen, Fuming Wang

• June 18, 2026

Cross-Linked HA Did Not Outperform Saline

Two single-injection cross-linked hyaluronic acid formulations showed no statistically significant advantage over saline for pain or functional outcomes through 24 weeks.

• by Andrea Surnit

• July 10, 2026

• 4 min